エピソード

  • Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR

    Racial/Ethnic Disparities in TDR, DME, and Other Vision Threats in Patients With DR
    2026/04/15
    Are patients with DR at higher risk for TDR, DME, vitreous hemorrhage, or blindness based on race or ethnicity ? Jordan Deaner, MD, moderates a discussion with Vaidehi Dedania, MD, and Rehan Hussain, MD, about a large retrospective cohort study examining more than 627,000 US patients with DR. The panel examines why Black and Hispanic patients faced significantly higher rates of adverse outcomes at 1 and 5 years after diagnosis and unpacks what confounding variables the study could not capture. They consider what these findings should mean for screening strategies, patient education, and the day-to-day management of high-risk diabetic patients in clinic.
    続きを読む 一部表示
    16 分
  • GLP-1 Use and AMD Risk

    GLP-1 Use and AMD Risk
    2026/03/19
    Could GLP-1s originally designed for diabetes and weight loss influence the risk of developing wet AMD? In this episode of New Retina Radio Journal Club with VBS, host Barton Blackorby, MD, is joined by Katharine Talcott, MD, and Hong-Uyen Hua, MD, to discuss a large national cohort study examining the relationship between GLP-1s and AMD. They explore potential biologic mechanisms, how big-data analyses are shaping retina research, and what these findings could mean for future AMD studies.
    続きを読む 一部表示
    17 分
  • Spotlight on UNITY® VCS: Intelligent Fluidics

    Spotlight on UNITY® VCS: Intelligent Fluidics
    2026/03/16
    In this episode of RetinaLive focused on UNITY® VCS|CS, Jay Sridhar, MD welcomes Steve Charles, MD, FACS, FICS, FASRS and Maria Berrocal, MD for an in-depth conversation on the evolution of vitreoretinal surgery. The panel discusses the historical context of surgical technology, practical considerations for fluidics and intraoperative control, and the importance of adapting techniques for complex cases. Through real-world examples and expert perspectives, listeners will gain valuable insights into surgical decision-making, efficiency and the future of surgical retinal procedures. For Important Product Information, visit unityvcs.com. Disclaimers: Featured surgeons are paid Alcon consultants. The views expressed are their own. 8:57: Compared to HYPERVIT 20K 10:53: 5,000 cSt sillicone oil through 25 Ga cannulas, 1,000 cSt silicone oil through 25 Ga cannulas, up to 80% faster flow rate, all gauges (23 Ga, 25 Ga and 27 Ga entry system), based on bench data 20:45: Compared to CONSTELLATION® Vision System. Based on bench data. References: Alcon Data on File, 2024. [REF-24615] Alcon Data on File, 2024. [REF-24379] Alcon Data on File, 2024. [REF-24576] UNITY VCS and CS User Manual Alcon Data on File, 2024. [REF-24644] Vasavada V, et al. Real-time dynamic intraocular pressure fluctuations during microaxial phacoemulsification using different aspiration flow rates and their impact on early postoperative outcomes: a randomized clinical trial. Journal of Cataract & Refractive Surgery. 2014:30(8);534-540. Vasavada, AR, et al. Impact of high and low aspiration parameters on postoperative outcomes of phacoemulsification randomized clinical trial. Journal of Cataract & Refractive Surgery. 2010:36(4);588-593. Alcon Data on File, 2024. [REF-24899] Alcon Data on File, 2024. [REF-25374] Alcon Data on File, 2025. [REF-28170] NGENUITY 3D Visualization System User Guide 1.5 Manual. Bergamo VC, Caiado RR, Maia A. Et al, role of vital dyes in chromovirectomy. Asia Pac J Ophthalmol. 2021;10(1):26-38. Alcon Data on File, 2024. [REF-25563] Sponsored by Alcon, Inc. © 2026 Alcon Inc. 02/26 US-UVC-2600032
    続きを読む 一部表示
    22 分
  • The Fellow Eye: Episode 3

    The Fellow Eye: Episode 3
    2026/03/05
    Co-hosts David Fell, MD, and Justin C. Muste, MD, are joined by Danny Mammo, MD, and Sean Berkowitz, MD, MBA, to talk all things uveitis, including challenging (and rewarding!) cases. They discuss signs of uveitis masqueraders, when to consider a diagnostic vitrectomy, how to manage patients at risk of being lost to follow-up, and ways to manage endophthalmitis.
    続きを読む 一部表示
    44 分
  • Mentoring in Retina: Addressing Economic Diversity

    Mentoring in Retina: Addressing Economic Diversity
    2026/02/24
    Katherine E. Talcott, MD, sits down with retina mentors Yoshihiro Yonekawa, MD, and Adrienne W. Scott, MD, to discuss various strategies mentors and programs can implement to better support trainees who hale from diverse economic backgrounds.
    続きを読む 一部表示
    23 分
  • New Retina Radio Journal Club w/ VBS: Outcomes for PDR Patients LTFU for at Least 1 Year

    New Retina Radio Journal Club w/ VBS: Outcomes for PDR Patients LTFU for at Least 1 Year
    2026/02/19
    How did patients with PDR fare after being lost to follow-up for at least 1 year and then returning to the clinic? Kyle Kovacs, MD, is joined by Matt Starr, MD, and Nita Valikodath, MD, MS, to explore a recent paper that leveraged the power the IRIS Registry to assess real-world outcomes for this important subset of patients.
    続きを読む 一部表示
    22 分
  • The Fellow Eye: Episode 2

    The Fellow Eye: Episode 2
    2026/02/12
    Podcast co-hosts David Fell, MD, and Justin Muste, MD, are joined by Joshua H. Uhr, MD, and Arnulfo Garza-Reyes, MD, to share their experiences with scleral buckling. They discuss the utility of buckling for various cases, encircling bands versus elements, and tips for surgical success.
    続きを読む 一部表示
    44 分
  • The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA Treatment

    The Race to Slow GA: A Retina Specialist in the Driver’s Seat of GA Treatment
    2026/02/05
    Are you ready to accelerate your understanding of retina care?Join Dr. Nemo Patel as he speaks with Dr. Patrick Staropoli, a fellow retina specialist and professional race car driver, in an engaging discussion about Geographic Atrophy (GA) secondary to AMD.In this episode, Dr. Staropoli shares how the principles of racing—split-second decision-making, teamwork, and maintaining focus under pressure—influence his approach to treating GA. Together, they'll explore the evolving GA treatment landscape and emphasize the critical role of early detection and timely referral. Please see full Prescribing Information at http://bit.ly/4jXHTsb. This episode is sponsored by Apellis Pharmaceuticals, which developed its content and compensated the speakers.
    続きを読む 一部表示
    19 分